Literature DB >> 24099702

N-terminal domain of the androgen receptor contains a region that can promote cytoplasmic localization.

Javid A Dar1, Kurtis Eisermann, Khalid Z Masoodi, Junkui Ai, Dan Wang, Tyler Severance, Sharanya D Sampath-Kumar, Zhou Wang.   

Abstract

Nucleocytoplasmic trafficking of the androgen receptor (AR) represents an essential step in androgen action. To determine whether the amino-terminal domain (NTD) contains potential nuclear import and/or export signals, deletion mutants of the NTD tagged with green fluorescent protein (GFP) were generated and tested for their intracellular localization in both AR-negative and AR-positive cell lines. Subcellular localization analysis suggested a role of the NTD in regulating AR subcellular localization and revealed that the region of a.a. 50-250 of the NTD of AR (AR(50-250)) could promote cytoplasmic localization. Leptomycin B inhibited the activity of AR(50-250), suggesting that AR(50-250) export is mediated through exportin 1, either directly or indirectly. These observations argue for an important role of the NTD in regulating AR nucleocytoplasmic trafficking and will facilitate further investigation of interactions among different signals in regulating AR nucleocytoplasmic trafficking, which may lead to new approaches to inhibit AR nuclear localization.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AR(50–250); Androgen receptor; Leptomycin B; NTD; Subcellular localization

Mesh:

Substances:

Year:  2013        PMID: 24099702      PMCID: PMC3858452          DOI: 10.1016/j.jsbmb.2013.09.013

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  32 in total

Review 1.  Transport of proteins and RNAs in and out of the nucleus.

Authors:  S Nakielny; G Dreyfuss
Journal:  Cell       Date:  1999-12-23       Impact factor: 41.582

2.  Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells.

Authors:  R K Tyagi; Y Lavrovsky; S C Ahn; C S Song; B Chatterjee; A K Roy
Journal:  Mol Endocrinol       Date:  2000-08

Review 3.  Trafficking of nuclear receptors in living cells.

Authors:  G L Hager; C S Lim; C Elbi; C T Baumann
Journal:  J Steroid Biochem Mol Biol       Date:  2000-11-30       Impact factor: 4.292

4.  The Hsp90 inhibitor, 17-AAG, prevents the ligand-independent nuclear localization of androgen receptor in refractory prostate cancer cells.

Authors:  Anthony J Saporita; Junkui Ai; Zhou Wang
Journal:  Prostate       Date:  2007-04-01       Impact factor: 4.104

5.  Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen.

Authors:  C W Gregory; R T Johnson; J L Mohler; F S French; E M Wilson
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

6.  Regulation of androgen receptor activity by tyrosine phosphorylation.

Authors:  Zhiyong Guo; Bojie Dai; Tianyun Jiang; Kexin Xu; Yingqiu Xie; Oekyung Kim; Issa Nesheiwat; Xiangtian Kong; Jonathan Melamed; Venkatesh D Handratta; Vincent C O Njar; Angela M H Brodie; Li-Rong Yu; Timothy D Veenstra; Hegang Chen; Yun Qiu
Journal:  Cancer Cell       Date:  2006-10       Impact factor: 31.743

Review 7.  Structural features discriminate androgen receptor N/C terminal and coactivator interactions.

Authors:  Emily B Askew; John T Minges; Andrew T Hnat; Elizabeth M Wilson
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

8.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

9.  Inhibition of glycogen synthase kinase-3beta promotes nuclear export of the androgen receptor through a CRM1-dependent mechanism in prostate cancer cell lines.

Authors:  Stefanie V Schütz; Marcus V Cronauer; Ludwig Rinnab
Journal:  J Cell Biochem       Date:  2010-04-15       Impact factor: 4.429

10.  HDAC6 regulates androgen receptor hypersensitivity and nuclear localization via modulating Hsp90 acetylation in castration-resistant prostate cancer.

Authors:  Junkui Ai; Yujuan Wang; Javid A Dar; June Liu; Lingqi Liu; Joel B Nelson; Zhou Wang
Journal:  Mol Endocrinol       Date:  2009-10-23
View more
  8 in total

1.  Splicing Factor Prp8 Interacts With NES(AR) and Regulates Androgen Receptor in Prostate Cancer Cells.

Authors:  Dan Wang; Minh M Nguyen; Khalid Z Masoodi; Prabhpreet Singh; Yifeng Jing; Katherine O'Malley; Javid A Dar; Rajiv Dhir; Zhou Wang
Journal:  Mol Endocrinol       Date:  2015-09-15

2.  Regulation and targeting of androgen receptor nuclear localization in castration-resistant prostate cancer.

Authors:  Shidong Lv; Qiong Song; Guang Chen; Erdong Cheng; Wei Chen; Ryan Cole; Zeyu Wu; Laura E Pascal; Ke Wang; Peter Wipf; Joel B Nelson; Qiang Wei; Wenhua Huang; Zhou Wang
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

3.  Inhibition of Androgen Receptor Nuclear Localization and Castration-Resistant Prostate Tumor Growth by Pyrroloimidazole-based Small Molecules.

Authors:  Khalid Z Masoodi; Yadong Xu; Javid A Dar; Kurtis Eisermann; Laura E Pascal; Erica Parrinello; Junkui Ai; Paul A Johnston; Joel B Nelson; Peter Wipf; Zhou Wang
Journal:  Mol Cancer Ther       Date:  2017-06-27       Impact factor: 6.261

4.  Development and Implementation of a High-Throughput High-Content Screening Assay to Identify Inhibitors of Androgen Receptor Nuclear Localization in Castration-Resistant Prostate Cancer Cells.

Authors:  Paul A Johnston; Minh M Nguyen; Javid A Dar; Junkui Ai; Yujuan Wang; Khalid Z Masoodi; Tongying Shun; Sunita Shinde; Daniel P Camarco; Yun Hua; Donna M Huryn; Gabriela Mustata Wilson; John S Lazo; Joel B Nelson; Peter Wipf; Zhou Wang
Journal:  Assay Drug Dev Technol       Date:  2016-05       Impact factor: 1.738

5.  The N-terminal domain of the androgen receptor drives its nuclear localization in castration-resistant prostate cancer cells.

Authors:  Javid A Dar; Khalid Z Masoodi; Kurtis Eisermann; Sudhir Isharwal; Junkui Ai; Laura E Pascal; Joel B Nelson; Zhou Wang
Journal:  J Steroid Biochem Mol Biol       Date:  2014-03-22       Impact factor: 4.292

Review 6.  Drug discovery in advanced prostate cancer: translating biology into therapy.

Authors:  Timothy A Yap; Alan D Smith; Roberta Ferraldeschi; Bissan Al-Lazikani; Paul Workman; Johann S de Bono
Journal:  Nat Rev Drug Discov       Date:  2016-07-22       Impact factor: 84.694

7.  Poly (A) Binding Protein Cytoplasmic 1 Is a Novel Co-Regulator of the Androgen Receptor.

Authors:  Kurtis Eisermann; Javid A Dar; Jun Dong; Dan Wang; Khalid Z Masoodi; Zhou Wang
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

Review 8.  Recent advances on the progressive mechanism and therapy in castration-resistant prostate cancer.

Authors:  Keshan Wang; Hailong Ruan; Tianbo Xu; Lei Liu; Di Liu; Hongmei Yang; Xiaoping Zhang; Ke Chen
Journal:  Onco Targets Ther       Date:  2018-05-28       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.